Xsolis’ Post

As we kick off day 2 of the Innovation Network Gathering, here's an important highlight from yesterday. Donna Mongiello, RN, BSN, explained the significance of a configurable, multi-tenant platform and why this building block for clinical trial technology is required for a step-change in the acceleration of clinical trials. #ING2024 #clinicaltrialtechnology

If you did not have a chance to join us at the innovation network take a listen to what SME Donna Mongiello unveils in terms of what others are claiming and YPrime is delivering! See how our innovations are reimagining the clinical trial experience in terms of cycle times, quality and value for #pharma, #sites, & #patients

It's important for those involved with selecting #clinicaltrial #tech to understand the significance of a #multitenant platform.

When choosing a technology vendor, it’s important to consider the critical value of a fully configurable, multi-tenant platform so that when changes need to happen for a study it is replicated instantly throughout the software rather than at the singular codebase that is highly prone to errors and lost time in implementation.

🚀 New Data Source! 🚀 Segmed, Inc. and Datavant are joining forces to revolutionize patient insights with advanced imaging data integration. This strategic partnership will leverage Segmed, Inc.'s vast collection of imaging studies and integrate them within the Datavant Ecosystem, offering an in-depth, longitudinal view of real-world imaging data. Together, we aim to accelerate healthcare innovation by enhancing patient profiles with comprehensive data from various sources, including clinical trials and EHRs. Read the full announcement to discover how this partnership will drive impactful advancements in healthcare: https://hubs.ly/Q02D164C0 #datalogistics #HealthcareInnovation #DataIntegration #PatientInsights #HealthTech

Today, GE HealthCare announced the launch of the new Voluson Signature series to help providers speed up exam times and tailor precision care for women.    Powered with advanced tools and #AI-powered innovation, potential women’s health issues can be detected much earlier and faster with these systems. The Voluson Signature 18 and 20 combine high-performance hardware with flexible, scalable software to help increase clinicians’ confidence in their diagnostic and treatment determinations, enhancing quality care delivery for patients.    This launch builds on GE HealthCare’s Voluson portfolio and impressive legacy of exceptional image quality and intelligent workflows. With the inclusion of AI-driven innovation, we can further our goal to enable the highest quality of care for patients.    Read more about this news here: https://lnkd.in/gDQJHhBf     #GEHealthCare #FutureofHealthcare #Efficiency #MedTech #WomensHealth #Ultrasound

8 years ago, I founded Eniax driven by a simple yet powerful realization: healthcare communication was lagging behind, and it was costing us more than just administrative headaches—it was costing us the quality of patient care. In 2016, I founded Eniax with a clear purpose. After witnessing the inefficiencies in company-customer communication, especially in healthcare, I knew things had to change. The administrative costs tied to poor communication are staggering, and patients deserve so much better. Healthcare providers should focus on building meaningful relationships with their patients, not just on scheduling appointments. That’s where Eniax comes in. We’re on a mission to revolutionize healthcare communication using cutting-edge AI technology to foster better connections between providers and patients. Imagine a healthcare system where every interaction is meaningful, where both patients and providers feel valued and empowered. That’s the future we’re building at Eniax. If you're a healthcare decision-maker passionate about improving patient care, let's connect. Together, we can create a healthcare system that truly puts patients first. #HealthcareInnovation #PatientCare #HealthTech #Eniax #BetterHealthcare

Emerging DTx companies may not have such an easy path forward in 2024.  🔺How can they overcome such a tough reimbursement environment?  🔺What evidentiary support is needed for clinicians to fully trust #DTx? In a recent article from Endpoints News, DTx industry insider Rick Bartels, MBA says we are in a transition period. DTx companies will need to explore different ways to reach funding goals and prove the impact of their treatments. Industry experts Shaheen E Lakhan, MD, PhD, FAAN, Bob Schafer and John Wagner, MD, PhD join forces in our latest webinar to discuss how DTx companies can navigate the evolving digital health technology landscape and generate quality data. Watch the Webinar on-demand: https://bit.ly/48jKcPv Read More from Endpoints: https://lnkd.in/gvQbm-2u

The threat of a potentially large recall or field corrective action is enough to overwhelm even the most diligent of companies. As a result, more organizations are relying on outsourced solutions from trusted partners who can focus on these protocols. Learn how #IQVIA #MedTech helped a global imaging company with their field action, resulting in a 95% response rate. https://bit.ly/48FA8jB

Are you attending #UNOSTMF2024 in Louisville, Kentucky next week? I’m thrilled to connect with transplant leaders like you at booth #216! Stop by and meet our @eHealth Technologies team and learn how our patented technology is revolutionizing clinical workflows. Let's talk about simplifying your processes for faster, more organized medical histories. See you there! #healthtech #transplantleaders #clinicalworkflow